varvis®

Limbus Medical Technologies GmbH, founded in 2015 in Rostock, Germany, develops the varvis® cloud-based genomics software platform. This platform is designed for clinical routine diagnostics, enhancing patient diagnosis by supporting the entire next-generation sequencing (NGS) workflow. varvis® is the first genomics software certified as a Class C medical device under the European In Vitro Diagnostic Regulation (IVDR). The varvis® platform offers a clinical decision support system that processes raw NGS data through an automated bioinformatics pipeline. It performs tasks such as alignment, variant calling, and annotation of various genomic variants. The software integrates data management, variant interpretation, and reporting in a standardized manner, aiding clinical decision-making. Additionally, the allexes® database provides continuously updated variant annotation data, ensuring compliance with data privacy regulations. Limbus Medical Technologies also offers support, training, and validation services to facilitate smooth integration in clinical laboratories. The platform is utilized by diagnostic laboratories across Europe, Canada, and the USA, improving patient care through advanced genomic analysis.

• Employees 28
• Founded 2015